Literature DB >> 16177963

Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer.

Karoliina Tuppurainen1, Johanna M Mäkinen, Oili Junttila, Annikki Liakka, Atte P Kyllönen, Hannu Tuominen, Tuomo J Karttunen, Markus J Mäkinen.   

Abstract

Colorectal serrated adenocarcinoma originates from serrated adenoma, but definite histological criteria have not yet been established. It presents with frequent DNA microsatellite instability (MSI), but the frequency of low-level (MSI-L) and high-level MSI (MSI-H) and the expression of mismatch-repair (MMR) enzymes in serrated adenocarcinoma are not known. To address these questions, morphological criteria for serrated cancers were established, their validity was tested, and MSI analysis was performed with NIH consensus markers and MMR enzyme immunohistochemistry for hMLH1, hMSH2, and hMSH6 in 35 serrated and 75 non-serrated colorectal carcinomas. Serrated carcinomas frequently showed a serrated, mucinous or trabecular growth pattern; abundant eosinophilic cytoplasm; chromatin condensation; preserved polarity; and the absence of necrosis. With these features, it was possible to distinguish them from non-serrated cancers, with the mean kappa score for five observers being 0.509. MSI analysis was successful in 31 serrated and 73 non-serrated carcinomas. 54.8% of serrated carcinomas were microsatellite-stable (MSS), 29.0% presented with MSI-L, and 16.1% presented with MSI-H, whereas 78.1% of non-serrated carcinomas were MSS, 13.7% were MSI-L, and 8.2% were MSI-H. MSI-L was more common in serrated cancers (p=0.035) and it was associated with patchy immunohistochemical staining (33.3%) of MLH1. MSI-H did not differ between serrated and non-serrated cancers (p=0.14). These results suggest that the biological background of serrated carcinomas differs from sporadic non-serrated colorectal cancer, but is not directly related to MSI. Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177963     DOI: 10.1002/path.1850

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  40 in total

1.  Annexin A10 is a marker for the serrated pathway of colorectal carcinoma.

Authors:  Sara A Sajanti; Juha P Väyrynen; Päivi Sirniö; Kai Klintrup; Jyrki Mäkelä; Anne Tuomisto; Markus J Mäkinen
Journal:  Virchows Arch       Date:  2014-11-14       Impact factor: 4.064

2.  Variations in Metastasis Site by Primary Location in Colon Cancer.

Authors:  Ramzi Amri; Liliana G Bordeianou; Patricia Sylla; David L Berger
Journal:  J Gastrointest Surg       Date:  2015-05-02       Impact factor: 3.452

Review 3.  Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.

Authors:  Oscar Murcia; Miriam Juárez; Eva Hernández-Illán; Cecilia Egoavil; Mar Giner-Calabuig; María Rodríguez-Soler; Rodrigo Jover
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 4.  Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.

Authors:  Jinru Shia; Susanne Holck; Giovanni Depetris; Joel K Greenson; David S Klimstra
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 5.  Serrated pathway: alternative route to colorectal cancer.

Authors:  Arpád V Patai; Béla Molnár; Zsolt Tulassay; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

6.  Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma.

Authors:  Hailong Zhu; Huali Qin; Ziling Huang; Shuai Li; Xuyou Zhu; Jian He; Jing Yang; Xiaoting Yu; Xianghua Yi
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

7.  Downregulation of the hedgehog receptor PTCH1 in colorectal serrated adenocarcinomas is not caused by PTCH1 mutations.

Authors:  Karoliina Stefanius; Tiina Kantola; Anne Tuomisto; Pia Vahteristo; Tuomo J Karttunen; Lauri A Aaltonen; Markus J Mäkinen; Auli Karhu
Journal:  Virchows Arch       Date:  2011-01-14       Impact factor: 4.064

8.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.

Authors:  Maria Caruso; James Moore; Gregory J Goodall; Michelle Thomas; Stuart Phillis; Anna Tyskin; Glenice Cheetham; Nancy Lerda; Hiroyuki Takahashi; Andrew Ruszkiewicz
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

9.  Pathological features of colorectal carcinomas in MYH-associated polyposis.

Authors:  A M O'Shea; S P Cleary; M A Croitoru; H Kim; T Berk; N Monga; R H Riddell; A Pollett; S Gallinger
Journal:  Histopathology       Date:  2008-06-28       Impact factor: 5.087

Review 10.  [Serrated pathway of colorectal carcinogenesis].

Authors:  G B Baretton
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.